Back to search

Article

Pre-TCR-Targeted Immunotherapy for T-cell Acute Lymphoblastic Leukemia

2024-06-02

Abstract excerpt

<h4>SUMMARY</h4> Targeted immunotherapy for T-cell acute lymphoblastic leukemia (T-ALL), an aggressive tumor of developing T-cell progenitors, is an urgent unmet need, especially for relapsed/refractory (r/r) disease. Selective T-ALL targeting is challenging due to the shared antigen expression between leukemic and normal T cells. Here we identify the pre-TCR, a surface receptor essential for T-cell development,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bbbcf130-f83c-5ebd-8e14-3706b603f50b
DOI
10.1101/2024.05.29.596375
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pre-TCR-Targeted Immunotherapy for T-cell Acute Lymphoblastic LeukemiaDOI 10.1101/2024.05.29.596375
Select a neighboring publication to make it the new centre.